Global Surgical Site Infection Control Market Overview 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Surgical site infection control Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Surgical site infection control market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global surgical site infection control market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.1% during 2023-2028.

Surgical site infection control encompasses the protocols, guidelines, and measures implemented to prevent infections within the operated area. It involves sterile techniques, equipment sterilization, airflow control in operating rooms, and surgical team hygiene practices. It includes patient screening for potential infection risks, administering prophylactic antibiotics, proper skin preparation, and other preparatory steps. It reduces the occurrence of infections at surgical sites, contributing to patient safety. It helps in reducing additional medical costs related to treatment and extended hospital stays. Besides this, it minimizes postoperative complications and promotes quicker recovery. It finds applications in various surgical fields, including general surgery, orthopedics, and cardiovascular surgery.

Global Surgical Site Infection Control Market Trends and Drivers:

The rise in the number of surgical procedures performed globally due to an aging population, chronic diseases, and medical advancements represents one of the key factors catalyzing the demand for effective surgical site infection control measures. Additionally, the increasing awareness among healthcare professionals and patients about the importance of infection control is leading to a greater focus on implementing surgical site infection control measures. Apart from this, the introduction of new technologies, such as advanced sterilization equipment and antimicrobial dressings, is positively influencing the market. Moreover, the governing authorities of various countries and international organizations are promoting public health campaigns focusing on infection prevention, which is propelling market growth.

Global Surgical Site Infection Control Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Mérieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson Johnson, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Prescient Surgical, Steris Corporation

The report segmented the market on the basis of region, product, infection type, surgery type and end user.

Breakup by Product:

• Antibiotic Prophylaxis Products
• Wound Care Dressings
• Surgical Drapes
• Surgical Clippers
• Antiseptics and Disinfectants
• Wound Irrigation Products
• Others

Breakup by Infection Type:

• Superficial Incisional SSI
• Deep Incisional SSI
• Organ or Space SSI

Breakup by Surgery Type:

• Cesarean Section
• Gastric Bypass
• Cataract Surgery
• Dental Restoration
• Others

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800